SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Genta, Inc. (GNTA) -- Ignore unavailable to you. Want to Upgrade?

To: bob zagorin who wrote (1600)6/1/2002 8:39:29 AM
From: capt rocky 1  Respond to of 1870
 
the marketing and production deal is the cherry on the sundae. it would take years to get the ball rolling from scratch. we will be in europe immediately. rocky



To: bob zagorin who wrote (1600)6/3/2002 9:23:46 AM
From: Elmer  Read Replies (2) | Respond to of 1870
 
<there's no way they would make this agreement if they didn't think the odds were heavily in favor of success>

They certainly bought on the cheap. They picked up 10% of the stock today at $10.79. They have also pushed a lot of risk back on GNTA with the structure of the deal. I don't think they pay anything else unless the drug is approved by the FDA. Sweet deal.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News